vs

Side-by-side financial comparison of INVO Fertility, Inc. (IVF) and Energous Corp (WATT). Click either name above to swap in a different company.

Energous Corp is the larger business by last-quarter revenue ($3.0M vs $1.8M, roughly 1.7× INVO Fertility, Inc.). Energous Corp runs the higher net margin — -43.6% vs -150.5%, a 106.9% gap on every dollar of revenue. On growth, Energous Corp posted the faster year-over-year revenue change (610.3% vs 22.6%). INVO Fertility, Inc. produced more free cash flow last quarter ($-1.8M vs $-2.4M). Over the past eight quarters, Energous Corp's revenue compounded faster (589.2% CAGR vs 12.8%).

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

Energous Corporation develops, manufactures and licenses patented radio frequency-based over-the-air wireless charging technologies and solutions. Its offerings cater to consumer electronics, wearables, IoT sensors, industrial and healthcare hardware segments, serving global hardware manufacturing clients across major regions worldwide.

IVF vs WATT — Head-to-Head

Bigger by revenue
WATT
WATT
1.7× larger
WATT
$3.0M
$1.8M
IVF
Growing faster (revenue YoY)
WATT
WATT
+587.7% gap
WATT
610.3%
22.6%
IVF
Higher net margin
WATT
WATT
106.9% more per $
WATT
-43.6%
-150.5%
IVF
More free cash flow
IVF
IVF
$662.4K more FCF
IVF
$-1.8M
$-2.4M
WATT
Faster 2-yr revenue CAGR
WATT
WATT
Annualised
WATT
589.2%
12.8%
IVF

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
IVF
IVF
WATT
WATT
Revenue
$1.8M
$3.0M
Net Profit
$-2.6M
$-1.3M
Gross Margin
37.5%
Operating Margin
-93.1%
-47.1%
Net Margin
-150.5%
-43.6%
Revenue YoY
22.6%
610.3%
Net Profit YoY
-62.2%
67.9%
EPS (diluted)
$-0.77
$-4.95

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVF
IVF
WATT
WATT
Q4 25
$3.0M
Q3 25
$1.8M
$1.3M
Q2 25
$1.9M
$975.0K
Q1 25
$1.6M
$343.0K
Q4 24
$1.7M
$428.0K
Q3 24
$1.4M
$230.0K
Q2 24
$1.8M
$46.0K
Q1 24
$1.6M
$64.0K
Net Profit
IVF
IVF
WATT
WATT
Q4 25
$-1.3M
Q3 25
$-2.6M
$-2.1M
Q2 25
$-5.3M
$-2.8M
Q1 25
$-17.4M
$-3.4M
Q4 24
$-3.6M
$-4.1M
Q3 24
$-1.6M
$-3.4M
Q2 24
$-2.2M
$-4.3M
Q1 24
$-1.6M
$-6.6M
Gross Margin
IVF
IVF
WATT
WATT
Q4 25
37.5%
Q3 25
36.0%
Q2 25
34.7%
Q1 25
35.2%
27.1%
Q4 24
41.4%
48.8%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Operating Margin
IVF
IVF
WATT
WATT
Q4 25
-47.1%
Q3 25
-93.1%
-172.2%
Q2 25
-160.4%
-285.1%
Q1 25
-1042.1%
-1052.8%
Q4 24
-202.0%
-820.8%
Q3 24
-90.7%
-1557.0%
Q2 24
-100.9%
-10110.9%
Q1 24
-95.7%
-10414.1%
Net Margin
IVF
IVF
WATT
WATT
Q4 25
-43.6%
Q3 25
-150.5%
-166.1%
Q2 25
-283.6%
-285.9%
Q1 25
-1060.1%
-981.3%
Q4 24
-211.3%
-964.7%
Q3 24
-113.8%
-1483.5%
Q2 24
-122.2%
-9256.5%
Q1 24
-101.3%
-10310.9%
EPS (diluted)
IVF
IVF
WATT
WATT
Q4 25
$-4.95
Q3 25
$-0.77
$-1.31
Q2 25
$-13.30
$-0.08
Q1 25
$-12.53
$-0.12
Q4 24
$14.86
$-60.42
Q3 24
$-15.11
$-14.98
Q2 24
$-22.39
$-0.65
Q1 24
$-7.55
$-1.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVF
IVF
WATT
WATT
Cash + ST InvestmentsLiquidity on hand
$10.4M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$5.8M
$12.5M
Total Assets
$18.8M
$16.7M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVF
IVF
WATT
WATT
Q4 25
$10.4M
Q3 25
$12.9M
Q2 25
$8.7M
Q1 25
$10.1M
Q4 24
$1.4M
Q3 24
$1.5M
Q2 24
$4.9M
Q1 24
$10.7M
Total Debt
IVF
IVF
WATT
WATT
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IVF
IVF
WATT
WATT
Q4 25
$12.5M
Q3 25
$5.8M
$13.7M
Q2 25
$2.6M
$8.8M
Q1 25
$3.3M
$9.5M
Q4 24
$12.7M
$-1.1M
Q3 24
$-23.3K
$434.0K
Q2 24
$1.4M
$3.0M
Q1 24
$10.2K
$7.2M
Total Assets
IVF
IVF
WATT
WATT
Q4 25
$16.7M
Q3 25
$18.8M
$17.8M
Q2 25
$19.3M
$12.3M
Q1 25
$31.7M
$13.4M
Q4 24
$46.4M
$3.8M
Q3 24
$17.0M
$4.0M
Q2 24
$17.8M
$7.2M
Q1 24
$17.3M
$13.1M
Debt / Equity
IVF
IVF
WATT
WATT
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVF
IVF
WATT
WATT
Operating Cash FlowLast quarter
$-1.8M
$-2.4M
Free Cash FlowOCF − Capex
$-1.8M
$-2.4M
FCF MarginFCF / Revenue
-101.6%
-80.5%
Capex IntensityCapex / Revenue
0.5%
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M
$-12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVF
IVF
WATT
WATT
Q4 25
$-2.4M
Q3 25
$-1.8M
$-2.5M
Q2 25
$-1.7M
$-2.9M
Q1 25
$-3.5M
$-4.7M
Q4 24
$-617.4K
$-2.7M
Q3 24
$-640.8K
$-4.0M
Q2 24
$-1.5M
$-5.8M
Q1 24
$-260.6K
$-5.1M
Free Cash Flow
IVF
IVF
WATT
WATT
Q4 25
$-2.4M
Q3 25
$-1.8M
$-2.5M
Q2 25
$-1.7M
$-2.9M
Q1 25
$-3.6M
$-4.7M
Q4 24
$-696.3K
Q3 24
$-4.1M
Q2 24
$-1.5M
$-5.8M
Q1 24
$-310.3K
$-5.1M
FCF Margin
IVF
IVF
WATT
WATT
Q4 25
-80.5%
Q3 25
-101.6%
-194.3%
Q2 25
-92.6%
-296.8%
Q1 25
-216.9%
-1367.1%
Q4 24
-40.6%
Q3 24
-1788.3%
Q2 24
-82.3%
-12667.4%
Q1 24
-19.7%
-7928.1%
Capex Intensity
IVF
IVF
WATT
WATT
Q4 25
1.3%
Q3 25
0.5%
0.5%
Q2 25
0.5%
1.6%
Q1 25
0.9%
6.1%
Q4 24
4.6%
0.0%
Q3 24
0.0%
28.3%
Q2 24
3.0%
123.9%
Q1 24
3.2%
1.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons